101 – 110 of 213
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay.
- Contribution to journal › Article
-
Mark
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
- Contribution to journal › Article
-
Mark
The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length
- Contribution to journal › Article
-
Mark
(68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes.
- Contribution to journal › Article
-
Mark
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
- Contribution to journal › Article
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
- Contribution to journal › Article
-
Mark
A New Look at Drugs Targeting Malignant Melanoma – An Application for Mass Spectrometry Imaging
- Contribution to journal › Scientific review
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
- Contribution to journal › Article
-
Mark
Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from sweden.
- Contribution to journal › Article
-
Mark
Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification.
- Contribution to journal › Article
